10-Year Follow-Up: Pembrolizumab Outshines Ipilimumab in Advanced Melanoma
Long-term study shows pembrolizumab's superior efficacy over ipilimumab for advanced melanoma patients.
Latest (Page 9)
Breakthrough Combo Therapy Shows Promise for Colorectal Cancer
New drug combination significantly improves outcomes for patients with advanced colorectal cancer
Immunotherapy Combo Boosts Survival in Advanced Bladder Cancer
Adding nivolumab to chemotherapy improves outcomes for patients with metastatic urothelial carcinoma
Erdafitinib Outperforms Chemo for Advanced Bladder Cancer with FGFR Mutations
Erdafitinib improves survival vs. chemo in metastatic urothelial cancer with FGFR alterations
Dual Immunotherapy Boosts Endometrial Cancer Outcomes
Durvalumab plus chemo followed by durvalumab +/- olaparib improves PFS in advanced endometrial cancer
Enzalutamide Improves Outcomes in High-Risk Prostate Cancer
Enzalutamide plus leuprolide or alone significantly delays metastasis in high-risk prostate cancer
Omega-3 Fatty Acids Fail to Prevent Paclitaxel-Induced Pain in Breast Cancer Patients
Study finds omega-3 supplements ineffective for preventing pain from paclitaxel chemotherapy in breast cancer
Aponermin Plus Standard Therapy Shows Promise for Relapsed Multiple Myeloma
Phase 3 trial finds aponermin combination improves outcomes in relapsed/refractory multiple myeloma patients
L-Glutamine: A Safe Supplement for Head and Neck Cancer Patients Undergoing Chemoradiotherapy
Study finds L-glutamine supplementation does not negatively impact survival in head and neck cancer patients
Oral Relugolix: A New Horizon in Prostate Cancer Treatment
Study shows oral relugolix has similar quality of life impact to leuprolide for prostate cancer patients
Fucoidan Boosts Quality of Life for Rectal Cancer Patients During Treatment
Study finds fucoidan supplement improves physical well-being in rectal cancer patients receiving chemoradiation
Blood Test Predicts Immunotherapy Response in Lung Cancer Patients
Study shows ctDNA blood test can predict immunotherapy response in advanced lung cancer patients
Identifying High-Risk Prostate Cancer Patients for Treatment Escalation
Study finds factors predicting early PSA failure in prostate cancer, suggesting need for more aggressive treatment